Accuracy of a Risk Alert Threshold for ICU Hypoglycemia: Retrospective Analysis of Alert Performance and Association With Clinical Deterioration Events.

Publication Year: 2022

DOI:
10.1097/CCM.0000000000005713

PMCID:
PMC9750112

PMID:
36519987

Journal Information

Full Title: Crit Care Med

Abbreviation: Crit Care Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Dr. Horton received support for article research from the University of Virginia Launchpad for Diabetes and the Frederick Thomas Advanced Medical Analytics Fund. Dr. Clark received funding from Nihon Kohden Digital Health Solutions, Inc; he disclosed that he is employed as a Principal Software Engineer and receives salary from Nihon Kohden Digital Health Solutions, Inc, and that he was employed by and owned stock in Advanced Medical Predictive Devices, Diagnostics, and Displays, Inc (AMP3D), which was acquired by Nihon Kohden in August 2021. Dr. Moorman disclosed that he was a shareholder in AMP3D, Inc, is a consultant for Nihon Kohden Digital Health Solutions, and owns stock in Medical Predictive Science Corporation. He is a consultant for Nihon Kohden Digital Health Solutions, Inc., with proceeds donated to the University of Virginia. The remaining authors have disclosed that they do not have any potential conflicts of interest."

Evidence found in paper:

"Supported, in part, by the University of Virginia Launchpad for Diabetes Program and the Frederick Thomas Advanced Medical Analytics Fund. Dr. Horton received support for article research from the University of Virginia Launchpad for Diabetes and the Frederick Thomas Advanced Medical Analytics Fund. Dr. Clark received funding from Nihon Kohden Digital Health Solutions, Inc; he disclosed that he is employed as a Principal Software Engineer and receives salary from Nihon Kohden Digital Health Solutions, Inc, and that he was employed by and owned stock in Advanced Medical Predictive Devices, Diagnostics, and Displays, Inc (AMP3D), which was acquired by Nihon Kohden in August 2021. Dr. Moorman disclosed that he was a shareholder in AMP3D, Inc, is a consultant for Nihon Kohden Digital Health Solutions, and owns stock in Medical Predictive Science Corporation. He is a consultant for Nihon Kohden Digital Health Solutions, Inc., with proceeds donated to the University of Virginia. The remaining authors have disclosed that they do not have any potential conflicts of interest."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025